Interstitial 6q deletion in a patient presenting with drug-resistant epilepsy and Prader-Willi like phenotype: An electroclinical description with literature review

Seizure. 2023 Jul:109:45-49. doi: 10.1016/j.seizure.2023.05.011. Epub 2023 May 14.

Abstract

Purpose: Interstitial 6q deletions are associated with rare genetic syndromes characterized by different signs, including developmental delay, dysmorphisms, and Prader-Willi (PWS)-like features. Drug-resistant epilepsy, a relatively rare finding in this condition, is often a challenge in terms of therapeutic approach. Our aim is to present a new case of interstitial 6q deletion and to conduct a systematic review of the literature with an emphasis on the neurophysiological and clinical traits of afflicted individuals.

Methods: We report a patient with an interstitial 6q deletion. Standard electroencephalograms (EEG), video-EEG with polygraphy and MRI features are discussed. We also conducted a literature review of previously described cases.

Results: We describe a relatively small interstitial 6q deletion (2 Mb circa), detected by CGH-Array, not encompassing the previously described 6q22 critical region for epilepsy occurrence. The patient, a 12-year-old girl, presented with multiple absence-like episodes and startle-induced epileptic spasms since the age of 11, with partial polytherapy control. Treatment with lamotrigine induced the resolution of startle-induced phenomena. From the literature review, we identified 28 patients with overlapping deletions, often larger than our patient's mutation. Seventeen patients presented with PWS-like features. Epilepsy was reported in 4 patients, and 8 patients presented abnormal EEG findings. In our patient, the deletion included genes MCHR2, SIM1, ASCC3, and GRIK2, but, interestingly, it did not encompass the 6q22 critical region for epilepsy occurrence. The involvement of GRIK2 in the deletion may play a role.

Conclusion: Literature data are limited, and specific EEG or epileptological phenotypes cannot yet be identified. Epilepsy, although uncommon in the syndrome, deserves a specific diagnostic workup. We speculate on the existence of an additional locus in the 6q16.1-q21 region, different from the already hypothesized q22, promoting the development of epilepsy in affected patients.

Keywords: Case report; Chromosomopathy; Epilepsy; Interstitial 6q deletion syndrome; Prader-Willi; Spasm.

Publication types

  • Systematic Review
  • Case Reports

MeSH terms

  • Chromosome Deletion
  • DNA Helicases / genetics
  • Drug Resistant Epilepsy* / complications
  • Drug Resistant Epilepsy* / drug therapy
  • Drug Resistant Epilepsy* / genetics
  • Epilepsy* / complications
  • Humans
  • Mutation
  • Phenotype
  • Prader-Willi Syndrome* / complications
  • Prader-Willi Syndrome* / drug therapy
  • Prader-Willi Syndrome* / genetics

Substances

  • ASCC3 protein, human
  • DNA Helicases